Chemotherapy by Numbers

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


A University of Michigan study has found that women with lower levels of education and/or income tend to get lower levels of something else—chemotherapy. Due to concerns or assumptions over how they will handle the side effects, doctors are three times more likely to give women with less education a reduced dose of chemotherapy.

The study, based on U.S. Census Bureau statistics and individual interviews, also found that women with less household income received less chemotherapy. The lead author of the study, Jennifer Griggs, said that doctors may have concerns over less educated patients’ possible misunderstanding the side effects of their treatments.

“It may be that negotiating side effects and continued doses of treatment is easier when there is more shared culture,” Griggs continued in a press release.

Doctors calculate chemotherapy doses based on height to weight ratio. Adjustments to the doses based on income or education can jeopardize survival rates for those patients.

“Simply put, this evidence shows that doctors are likely to reduce the chemotherapy levels for these women, even though there is no solid medical basis to do it,” said Gary Lyman, M.D., M.P.H., principal investigator and director of the ANC Study Group, a project that studies cancer patients starting chemotherapy that is funded by the pharmaceutical company Amgen.

— Caroline Dobuzinskis

Fact:

In-depth journalism that investigates the powerful takes real money and is so damn important right now.But it doesn’t take a Mother Jones investigation to know that billionaires and corporations will never fund the type of reporting (like they do politicians) we do that exists to help bring about change. Instead, our mission-driven journalism is made possible by people power, and has been for 46 years now since our founding as a non-profit.

In “TITLE TK” Monica Bauerlein writes about the perilous moment we’re in, and why it’s so important that we raise $325,000 by the time November’s midterms are decided so we can be ready to throw everything we have at the big issues facing the nation no matter what happens. Please help MoJo’s people-powered journalism with a donation today.

$400,000 to go!

payment methods

Fact:

In-depth journalism that investigates the powerful takes real money and is so damn important right now.But it doesn’t take a Mother Jones investigation to know that billionaires and corporations will never fund the type of reporting (like they do politicians) we do that exists to help bring about change. Instead, our mission-driven journalism is made possible by people power, and has been for 46 years now since our founding as a non-profit.

In “TITLE TK” Monica Bauerlein writes about the perilous moment we’re in, and why it’s so important that we raise $325,000 by the time November’s midterms are decided so we can be ready to throw everything we have at the big issues facing the nation no matter what happens. Please help MoJo’s people-powered journalism with a donation today.

$400,000 to go!

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate